The US Food and Drug Administration (FDA) has announced plans to update its organizational framework through a comprehensive revision to its Statement of Organization, Functions, and Delegations of Authority, codifying a broad internal realignment designed to centralize agency operations and modernize governance across multiple FDA components.
Published in the Federal